Literature DB >> 23443043

MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Ahmed Omran1, Dalia Elimam, Keith A Webster, Lina A Shehadeh, Fei Yin.   

Abstract

Cardiovascular diseases in children comprise a large public health problem. The major goals of paediatric cardiologists and paediatric cardiovascular researchers are to identify the cause(s) of these diseases to improve treatment and preventive protocols. Recent studies show the involvement of microRNAs (miRs) in different aspects of heart development, function, and disease. Therefore, miR-based research in paediatric cardiovascular disorders is crucial for a better understanding of the underlying pathogenesis of the disease, and unravelling novel, efficient, preventive, and therapeutic means. The ultimate goal of such research is to secure normal cardiac development and hence decrease disabilities, improve clinical outcomes, and decrease the morbidity and mortality among children. This review focuses on the role of miRs in different paediatric cardiovascular conditions in an effort to encourage miR-based research in paediatric cardiovascular disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443043      PMCID: PMC3748175          DOI: 10.1017/S1047951113000048

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  127 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.

Authors:  Ning Liu; Andrew H Williams; Yuri Kim; John McAnally; Svetlana Bezprozvannaya; Lillian B Sutherland; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

3.  Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  J Card Fail       Date:  2010-03-03       Impact factor: 5.712

4.  The incidence of asymptomatic hypertension in school children.

Authors:  Cihangir Akgun; Murat Dogan; Sinan Akbayram; Oguz Tuncer; Erdal Peker; Gökmen Taskin; Sükrü Arslan; Derya Arslan
Journal:  J Nippon Med Sch       Date:  2010-06       Impact factor: 0.920

5.  Argonaute-2-null embryonic stem cells are retarded in self-renewal and differentiation.

Authors:  P Chandra Shekar; Adnan Naim; D Partha Sarathi; Satish Kumar
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

6.  Clinical applications of miRNAs in cardiac remodeling and heart failure.

Authors:  Veli K Topkara; Douglas L Mann
Journal:  Per Med       Date:  2010-09-01       Impact factor: 2.512

7.  A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway.

Authors:  Limei Qin; Yaosheng Chen; Yuna Niu; Weiquan Chen; Qiwei Wang; Shuqi Xiao; Anning Li; Ying Xie; Jing Li; Xiao Zhao; Zuyong He; Delin Mo
Journal:  BMC Genomics       Date:  2010-05-23       Impact factor: 3.969

Review 8.  Targeting microRNAs in obesity.

Authors:  Huangming Xie; Lei Sun; Harvey F Lodish
Journal:  Expert Opin Ther Targets       Date:  2009-10       Impact factor: 6.902

Review 9.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways.

Authors:  Bernard R Wilfred; Wang-Xia Wang; Peter T Nelson
Journal:  Mol Genet Metab       Date:  2007-05-22       Impact factor: 4.797

10.  Adolescent overweight and future adult coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

View more
  12 in total

1.  Changes in microglial inflammation-related and brain-enriched MicroRNAs expressions in response to in vitro oxygen-glucose deprivation.

Authors:  Huimin Kong; Ahmed Omran; Muhammad Usman Ashhab; Na Gan; Jing Peng; Fang He; Liwen Wu; Xiaolu Deng; Fei Yin
Journal:  Neurochem Res       Date:  2013-12-12       Impact factor: 3.996

2.  Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.

Authors:  Ayan Biswas; Xueliang Pan; Melissa Meyer; Savita Khanna; Sashwati Roy; Gregory Pearson; Richard Kirschner; Patricia Witman; Esteban Fernandez Faith; Chandan K Sen; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

3.  Evaluation of epigenetic alterations (mir-126 and mir-155 expression levels) in Mexican children exposed to inorganic arsenic via drinking water.

Authors:  Mónica S Pérez-Vázquez; Ángeles C Ochoa-Martínez; Tania RuÍz-Vera; Yesenia Araiza-Gamboa; Iván N Pérez-Maldonado
Journal:  Environ Sci Pollut Res Int       Date:  2017-10-06       Impact factor: 4.223

4.  Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy.

Authors:  Muhammad Usman Ashhab; Ahmed Omran; Huimin Kong; Na Gan; Fang He; Jing Peng; Fei Yin
Journal:  J Mol Neurosci       Date:  2013-05-01       Impact factor: 3.444

Review 5.  The roles of epicardial adipose tissue in heart failure.

Authors:  Ying Song; Fei Song; Chan Wu; Yi-Xiang Hong; Gang Li
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

6.  Effects of MRP8, LPS, and lenalidomide on the expressions of TNF-α , brain-enriched, and inflammation-related microRNAs in the primary astrocyte culture.

Authors:  Ahmed Omran; Muhammad Usman Ashhab; Na Gan; Huimin Kong; Jing Peng; Fei Yin
Journal:  ScientificWorldJournal       Date:  2013-09-21

Review 7.  MicroRNAs in congenital heart disease.

Authors:  Tanya Smith; Cha Rajakaruna; Massimo Caputo; Costanza Emanueli
Journal:  Ann Transl Med       Date:  2015-12

Review 8.  MicroRNAs: new insights into chronic childhood diseases.

Authors:  Ahmed Omran; Dalia Elimam; Fei Yin
Journal:  Biomed Res Int       Date:  2013-06-27       Impact factor: 3.411

Review 9.  Exosomal miRNAs as potential biomarkers of cardiovascular risk in children.

Authors:  Abdelnaby Khalyfa; David Gozal
Journal:  J Transl Med       Date:  2014-06-10       Impact factor: 5.531

Review 10.  Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance.

Authors:  Kalupahana Irushi Pamodya Liyanage; Gamage Upeksha Ganegoda
Journal:  Biomed Res Int       Date:  2017-09-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.